Antimicrobial Resistance

Gain valuable insights into the pressing challenge of diagnosing gastrointestinal infections (GI) in the context of antimicrobial resistance (AMR)

With the landscape of healthcare rapidly evolving, diagnostic innovation, health equity, and the strategic value of laboratory services are emerging as critical focal points.

Antimicrobial resistance in Pseudomonas aeruginosa remains a serious health threat because multiple mechanisms may be involved that further complicate the management of infections.

Surgical-site infection (SSI) is one of the most common healthcare-associated infections (HAI) globally, and the most frequent postoperative complication

In recognition of World AMR Awareness Week (WAAW), this Viewpoints Series interview with pharmacist Jacob Morton explores the critical issue of limited public awareness about antimicrobial resistance (AMR) and its impact on patient healthcare.

An observational study conducted in Canada and published in Critical Care reveals significant financial implications of sepsis on post-hospitalization patient care.

Discover stories that highlight the realities faced by individuals battling superbugs and the vital role medical professionals play.

Explore 5 lessons from an AMS Pharmacist

Explore strategies for managing sepsis and AMR concurrently.

Explore strategies for managing sepsis and AMR concurrently.

In this MLO feature article, Chris Groke, Senior Medical Science Liaison at bioMérieux, breaks down the history of diagnostic innovation in the fight against antimicrobial resistance (AMR). As a Board-Certified Infectious Diseases Pharmacist, Groke shares knowledge and insight into the evolution of AMR and the critical role diagnostics play in addressing this global public health threat.

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Fifty-two medical specialty organizations and associations from across India are taking on antimicrobial resistance (AMR), paving the way for low- to middle-income countries looking to mitigate the impact of AMR. The country recognizes the severe impact caused by neglecting AMR, with over a million deaths attributed to AMR-related complications each year.

The antimicrobial stewardship (AMS) landscape is rapidly changing and diagnostics are revolutionizing how medical professionals meet AMS goals. In this CIDRAP ASP webinar and roundtable, experts discuss insights and share personal experiences regarding diagnostic trends and emerging opportunities for AMS.

A retrospective analysis of 382,149 Staphylococcus aureus isolates from U.S. Veterans Health Administration outpatients reveals significant shifts in antimicrobial resistance patterns over a 10-year period.

This groundbreaking study by Fernando and McKibbin employs sophisticated macroeconomic modeling to assess the global economic impacts of antimicrobial resistance (AMR) across G20 countries

This series covers advances in diagnostic and antimicrobial stewardship, focusing on multiplex PCR testing to combat MDROs and improve prescribing.

As part of a CIDRAP three-part webinar series, bioMérieux is proud to support this second installment that explores the shifting landscape of the rapid diagnostic laboratory, highlighting the transformative impact brought about by new technologies.

The Sepsis Alliance AMR Virtual Conference explores innovative solutions and educational initiatives for managing sepsis and combating antimicrobial resistance.

bioMérieux experts discuss how microbial identification and susceptibility testing can enhance antimicrobial stewardship and improve patient outcomes post-COVID.

CIDRAP-ASP explores AMR outcomes research through a socio-economic lens, emphasizing systems thinking and the integration of social sciences.

The BIOFIRE® BCID2 Panel uses rapid PCR technology to identify pathogens and resistance genes, improving antimicrobial stewardship, patient outcomes, and reducing hospital stay.

Scientists explore ocean biodiversity, uncovering potential new drug-producing biosynthetic pathways from marine microbes to combat drug resistance.

Learn how rapid diagnostics and surveillance can help detect and prevent the spread of Candida auris as U.S. infection rates continue to rise.

Read about how ribosome-binding antibiotics can enhance bacterial longevity and growth efficiency, challenging traditional views on antibiotic resistance.

NIH investigates emerging hypervirulent Klebsiella pneumoniae strains in community settings and their impact on infection severity and classification.

.

This briefing explores how outcomes research can highlight the value of rapid diagnostics in combating antimicrobial resistance and supporting antimicrobial stewardship

A study in Bangladesh highlights alarming antibiotic resistance and viral co-infections in children with diarrhea, worsening the health threat.

Learn about a study on antimicrobial resistance in post-traumatic wound infections in Uganda and the need for routine microbial diagnostics to guide treatment decisions.

ID pharmacists can improve antibiotic stewardship at discharge by identifying drug-related issues and optimizing prescriptions to reduce AMR risks.

Explore how artificial intelligence and machine learning are advancing the fight against infectious diseases, aiding in drug discovery, diagnostics, and outbreak control.

Research reveals mixed strain populations accelerate AMR in ICU patients, highlighting the need to limit bacterial spread to combat resistance.

Download the policy brief on the WHO’s Global Research Agenda for AMR in human health, outlining top research priorities to combat antimicrobial resistance by 2030.

Learn how the BIOFIRE® ME Panel impacts patient length of stay and supports antimicrobial stewardship in this exclusive interview with study authors.

This study highlights Germany's efforts to track AMR-related fatalities, improving national surveillance and antimicrobial stewardship strategies.

This article explores recent changes in bacterial taxonomy, their impact on microbiology, antimicrobial stewardship, and infection prevention

Antimicrobial resistance significantly increases hospital costs and length of stay, with a global economic burden reaching billions annually.

Results from the Society of Critical Care Medicine Discovery VIRUS international COVID-19 Registry aim to determine the rate and factors associated with early empiric antibiotic (EEAB) treatment to help set goals for antimicrobial stewardship efforts, in the post-pandemic era.

The Sepsis Alliance AMR Virtual Conference explores solutions for combating antimicrobial resistance and improving sepsis outcomes.

Rapid diagnostics and antimicrobial stewardship are key to optimizing sepsis outcomes by enabling timely, targeted testing and treatment decisions.

Sandra Vallejo discusses optimizing lab workflows and improving collaboration with healthcare providers at ECCMID 2023

An antimicrobial stewardship program at An-Najah National University Hospital significantly reduced antibiotic use and costs, according to a recent study.

A study in Cameroon highlights rising sepsis cases and AMR, emphasizing the need for surveillance, infection control, and antibiotic stewardship in hospitals.

A review of 52 studies finds ASPs reduce antibiotic use in hospital and non-hospital settings, including WHO Watch List drugs.

Innovative space planning is essential for lab safety, efficiency, and success, ensuring productivity and improved diagnostic outcomes

Chile uses cloud-based analytics to enhance antimicrobial stewardship by combining AMR data from over 40 hospitals for better patient and population outcomes.

A review of 148 studies links COVID-19 hospital surges to rising antimicrobial resistance, with 60.8% of bacterial co-infections resistant to treatment.

A study reveals the FDA-approved BPaL regimen may be less effective against multidrug-resistant TB meningitis due to limited drug penetration.

According to predictions from professor and practicing intensivist, Dr. Hannah Wunsch, war, multidrug resistance, climate change, emerging diseases, and reduced confidence in vaccination will be among the factors that influence an expected increase in infectious diseases in the ICU.

Rapid diagnostics help optimize antimicrobial stewardship for respiratory infections by identifying pathogens quickly, guiding treatment, and reducing AMR risks.

This study highlights the effectiveness of the VITEK® 2 AES in providing rapid, accurate antimicrobial susceptibility testing for Enterobacterales isolates.

Global antimicrobial resistance (AMR) — the “silent pandemic” — is already causing a significant burden on healthcare systems, with COVID-19 only adding to the complexity and challenge of this global public health threat.

In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI). 

COVID-19 may have accelerated AMR, highlighting the need for diagnostics and antimicrobial stewardship to manage bacterial coinfections

Explore the impact of the COVID-19 pandemic on antimicrobial stewardship programs and pneumonia diagnosis in this series featuring expert insights.

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota interviewed Christian Lillis, founder of the Peggy Lillis Foundation, about the fight against Clostridioides difficile through education, awareness, and reducing unnecessary antibiotic use.

Rapid diagnostics, like the BIOFIRE® FILMARRAY® Pneumonia Panel, are improving ICU pneumonia diagnosis in a multi-center trial across the UK.

A group of global experts from Italy, Lebanon, Thailand, India, the U.S., Colombia and China speak about the need for rapid diagnostic tests and efficient laboratory workflows for multi-drug resistant (MDR) Gram-negative infections.

Researchers around the world worked together to identify educational gaps and systemic barriers obstructing adherence to antimicrobial stewardship (AMS) principles in France, India, Mexico, and the United States.

The CDC's 2022 special report reveals a rise in multi-drug resistant organisms (MDROs) in U.S. hospitals during COVID-19, highlighting the impact of increased antimicrobial use.

Discover how new molecular technologies help labs interpret antimicrobial resistance results and support antibiotic stewardship efforts.

Researchers at TISH in Ethiopia used bioMérieux AST to study Gram-negative BSIs, finding high AMR rates in pediatric and ICU patients, urging intervention.

In this interview, microbiologist Andrea Prinzi discusses how diagnostic data can unite lab professionals, clinicians, and pharmacists to enhance antimicrobial stewardship.

Experts discuss pathology’s role in combating antimicrobial resistance and the importance of collaboration in clinical and academic settings.

A study with the University of Texas Health shows the BIOFIRE® FILMARRAY® Meningitis/Encephalitis Panel reduces hospital length of stay and antibiotic use.

bioMérieux pharmacist Tristan Timbrook and team analyzed data from the BIOFIRE® Pneumonia (PN) and BIOFIRE® Blood Culture Identification 2 (BCID2) Panels using BioFire Syndromic Trends, a cloud-based surveillance network software, to determine the prevalence of multi-drug resistant organisms (MDRO) across various US region

Experts in the Asia-Pacific region create consensus statements to optimize rapid diagnostic testing for antimicrobial stewardship in diverse healthcare settings.

This study evaluates the performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-negative blood cultures in a large hospital.

Next-generation sequencing (NGS) offers valuable insights for patient care, infection control, and public health when integrated with analysis software.

Biomarkers and syndromic testing help mitigate risks of AKI, AMR, and sepsis, aiding healthcare providers in improving patient care and outcomes.

The UK’s NHS adopts a subscription model for new antibiotics. Expert Emily Spivak, MD, discusses its global potential.

In their proof-of-concept study, Dr. Claeys and colleagues compared three rapid diagnostic test panels using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy, or DOOR MAT, to diagnose Gram-negative bloodstream infections.

Cindy Cook discusses the importance of surveillance and monitoring in combating antimicrobial resistance (AMR) and improving patient care

Dr. Gros offers steps for clinical lab managers to support antimicrobial stewardship in low- and middle-income countries to combat AMR.

Microbiology labs must update antimicrobial susceptibility testing breakpoints. Dr. Prinzi provides a step-by-step guide to ease the process.

This white paper urges a whole-system approach to infection detection, prevention, and management to combat antimicrobial resistance.

bioMérieux experts discuss the collaborative nature of diagnostic stewardship, focusing on PCR testing, NGS, and rapid tests to reduce diagnostic errors.

Advances in cloud, big data, and AI are making antimicrobial susceptibility testing data sharing more accessible, efficient, and equitable for all institutions.

A 2019 global study reveals 1.27 million deaths directly caused by antimicrobial resistance (AMR), a significant rise from previous estimates.

A PCT-based sepsis protocol in ICU patients cut antibiotic use and saved $1,200+ per patient without affecting mortality, per a study by Dr. Jarva Chow.

Professor Dan Morgan discusses how disease overestimation and anchoring bias influence antimicrobial prescribing in this ASHP podcast episode.

Three experts discuss antimicrobial stewardship during World Antimicrobial Awareness Week, addressing COVID-19 challenges, AMR research, and syndromic testing in ICU.

Discover how clinical microbiologists support antimicrobial stewardship programs in resource-limited settings, featuring experts from Pakistan, Nepal, and the USA.

Explore the challenges and successes of implementing antimicrobial stewardship programs in resource-limited settings in this ISID podcast episode.

Rapid diagnostic testing (RDT) is key to antimicrobial stewardship, but cost and lack of consensus hinder its widespread use.

Rapid diagnostics play a key role in antimicrobial stewardship, helping combat AMR through a One Health approach for patient and population health.

In this Rx Fridays episode, John Hurst, PharmD, discusses his career journey and the value of diagnostics and analytics in improving clinical pharmacy.

Learn how rapid diagnostics and antimicrobial stewardship programs can combat AMR with insights from experts Christine Ginocchio and Tristan Timbrook.

Dr. Allison Weinmann discusses the impact of COVID-19 on antimicrobial stewardship and prescribing trends in APIC's 5-Second Rule podcast.

The bioMérieux Antimicrobial Stewardship Challenge Game lets players solve clinical puzzles and apply stewardship principles in a fictional lab.

COVID-19 highlights the need for global collaboration in monitoring and combating antimicrobial resistance (AMR) through shared data and surveillance.

Explore antimicrobial stewardship in Spain with insights from pharmacist Eduardo Clot Silla on antibiotic use, resistance, and stewardship efforts nationwide.

Chile’s Collaborative Group for Antibiotic Resistance uses bioMérieux’s CLARION™ solution to automate AMR data collection, supporting nationwide surveillance and patient care.

Explore key metrics for evaluating antibiotic use and prescribing in outpatient settings, highlighting considerations for antimicrobial stewardship.

Experts share practical tips for enhancing patient awareness of antimicrobial resistance through community engagement, education, and effective communication.

The CDC's white paper discusses the importance of diagnostic stewardship in optimizing antibiotic use, reducing resistance, and improving patient outcomes

The Global Point Prevalence Survey monitors antimicrobial prescribing and resistance across hospitals worldwide, advancing stewardship and patient care efforts.

See the CDC white paper on advancing diagnostic stewardship to improve patient safety in healthcare-associated infections, antibiotic resistance, and sepsis.

Without new antibiotics and next-gen diagnostics, routine medical procedures could become too risky due AMR.

Dr. Ginocchio discusses IDSA diagnostic recommendations and One Health partnerships in the fight against AMR in this P.A.C.E.® accredited webinar.

Discover how data analytics can enhance lab effectiveness and antimicrobial stewardship in this expert presentation by Mike Broyles, PharmD.

Laboratories play a vital role in patient care and antimicrobial stewardship by providing actionable data to support physicians and pharmacists in combating AMR.

ECCMID has become one of the most comprehensive and influential congresses in the field of microbiology and infectious diseases, bringing together more than 14,000 colleagues from all over the world. 

AMR expert Marc Mendelson discusses the global impact of antibiotic resistance in low and middle-income countries and the need for equity in healthcare.

Experts explore how diagnostics help combat COVID-19 bacterial co-infections while addressing the rising threat of antimicrobial resistance.

Nurses play a crucial role in antimicrobial stewardship. Donna Bonanni, RN, MSN, shares insights on their impact in this Learning Lounge Viewpoints piece.

Experts discuss optimizing diagnostics in antimicrobial stewardship programs (ASPs) and the role of microbiology labs in Africa’s fight against AMR.

A study shows a 79% decline in ambulatory antibiotic prescriptions for respiratory infections, linked to rapid diagnostics for COVID-19 and influenza.

The PASTEUR Act aims to boost antibiotic development and support stewardship programs to improve patient outcomes and reduce healthcare costs.

A study targets hydrogen sulfide production to combat drug-resistant bacteria and preserve antibiotic effectiveness in future treatments.

Smithsonian researchers use ecological modeling to better predict pandemics and understand environmental factors contributing to antimicrobial resistance.

In this webinar, Dr. Joel Mortensen, Director of the Diagnostic Infectious Diseases Testing Laboratory at Cincinnati Children's Hospital, will explore the positive impact and untapped potential from using the BACT/ALERT® VIRTUO® blood culture system.

Explore the role of pharmacists in antimicrobial stewardship programs when hospitals lack on-site ID support. Featuring insights from Dr. Daniel J. Livorsi.

Blood culture diagnostics aid antimicrobial stewardship by improving pathogen ID and resistance detection. Expert John Hurst, PharmD, shares insights.

We invite you to download and share this comprehensive infographic to educate patients about the importance of infection prevention measures and the appropriate use of antimicrobials.

St. Bernard's Medical Center reduced C. difficile infection and mortality rates by over 60% using PCT-guided therapy and bioMérieux's CLARION solution.

Researchers explore effective storytelling tactics in top YouTube videos to engage audiences and support antimicrobial stewardship education.